These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 9345654)

  • 21. American Diabetes Association meetings, 1994. Insulin-dependent diabetes mellitus.
    Bloomgarden ZT
    Diabetes Care; 1994 Oct; 17(10):1237-9. PubMed ID: 7821160
    [No Abstract]   [Full Text] [Related]  

  • 22. Effects of mixing glargine and short-acting insulin analogs on glucose control.
    Kaplan W; Rodriguez LM; Smith OE; Haymond MW; Heptulla RA
    Diabetes Care; 2004 Nov; 27(11):2739-40. PubMed ID: 15505016
    [No Abstract]   [Full Text] [Related]  

  • 23. For parents. Type 1 diabetes research. Balancing hope with realism.
    Dinsmoor RS
    Diabetes Self Manag; 2003; 20(2):87-8, 91-2, 95, 99-102. PubMed ID: 12715738
    [No Abstract]   [Full Text] [Related]  

  • 24. A case of lipoatrophy with Lispro insulin without insulin pump therapy.
    Arranz A; Andia V; López-Guzmán A
    Diabetes Care; 2004 Feb; 27(2):625-6. PubMed ID: 14747261
    [No Abstract]   [Full Text] [Related]  

  • 25. Insulin therapy in diabetes mellitus: how can the currently available injectable insulins be most prudently and efficaciously utilised?
    Bell DS
    Drugs; 2007; 67(13):1813-27. PubMed ID: 17722952
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effect of the insulin analog lispro on nighttime blood glucose control in type 1 diabetic patients.
    Ahmed AB; Home PD
    Diabetes Care; 1998 Jan; 21(1):32-7. PubMed ID: 9538967
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pramlintide: FDA wants more.
    Diabetes Obes Metab; 2001 Oct; 3(5):386. PubMed ID: 11710342
    [No Abstract]   [Full Text] [Related]  

  • 28. 2008 resource guide. Insulin. Along with human insulin analogs, recombinant DNA human insulins are the most widely used insulins in this country. Through genetic engineering, bacteria or yeast are transformed into little "factories" that produce synthetic human insulin.
    Diabetes Forecast; 2008 Jan; 61(1):RG11-4. PubMed ID: 18290288
    [No Abstract]   [Full Text] [Related]  

  • 29. Symlin up close. How people are benefiting from this injected drug.
    Spake A
    Diabetes Forecast; 2008 Mar; 61(3):50-1. PubMed ID: 18446978
    [No Abstract]   [Full Text] [Related]  

  • 30. Pramlintide. AC 137, ACO 137, Normylin, Symlin, Tripro-amylin.
    Drugs R D; 1999 Aug; 2(2):118-22. PubMed ID: 10820656
    [No Abstract]   [Full Text] [Related]  

  • 31. New Insulins and New Aspects in Insulin Delivery.
    Woo VC
    Can J Diabetes; 2015 Aug; 39(4):335-43. PubMed ID: 26233724
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Insulin aspart: a review of its use in the management of type 1 and 2 diabetes mellitus.
    Chapman TM; Noble S; Goa KL
    Drugs; 2002; 62(13):1945-81. PubMed ID: 12215068
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Use of insulin glargine during pregnancy in a type 1 diabetic woman.
    Devlin JT; Hothersall L; Wilkis JL
    Diabetes Care; 2002 Jun; 25(6):1095-6. PubMed ID: 12032121
    [No Abstract]   [Full Text] [Related]  

  • 34. Postprandial glycaemia after regular and lispro insulin in children and adolescents with diabetes.
    Rami B; Schober E
    Eur J Pediatr; 1997 Nov; 156(11):838-40. PubMed ID: 9392394
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Novel pharmacologic agents for type 2 diabetes.
    Uwaifo GI; Ratner RE
    Endocrinol Metab Clin North Am; 2005 Mar; 34(1):155-97. PubMed ID: 15752927
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment with insulin lispro changes the insulin profile but does not affect the plasma concentrations of IGF-I and IGFBP-1 in type 1 diabetes.
    Hedman CA; Orre-Pettersson AC; Lindström T; Arnqvist HJ
    Clin Endocrinol (Oxf); 2001 Jul; 55(1):107-12. PubMed ID: 11453959
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Insulin's sidekicks. Developing alternative medications for type 1 diabetes.
    Berg EG
    Diabetes Forecast; 2013 Sep; 66(9):38-40. PubMed ID: 24156144
    [No Abstract]   [Full Text] [Related]  

  • 38. Prolonged efficacy of short acting insulin Lispro in combination with human ultralente in insulin-dependent diabetes mellitus.
    Burge MR; Waters DL; Holcombe JH; Schade DS
    J Clin Endocrinol Metab; 1997 Mar; 82(3):920-4. PubMed ID: 9062507
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Beyond insulin: what else might help?
    Scheiner G
    Diabetes Self Manag; 2014; 31(1):30, 32-4. PubMed ID: 24640060
    [No Abstract]   [Full Text] [Related]  

  • 40. [Portrait of a drug. Insulin lispro].
    Schatz H
    Krankenpfl J; 1999 Jun; 37(6):226-7. PubMed ID: 10524089
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.